Moderna begins first late-stage US trial of COVID-19 vaccine

Image of a woman in a lab coat holding scientific instruments.

Enlarge / A research
associate works at the Moderna Therapeutics Inc. lab in Cambridge,
Massachusetts. (credit: Bloomberg/Getty
Images
)

Moderna has given the first doses of its experimental
Covid-19 vaccine
to participants in what will be a
30,000-person trial, as the US moved into a new phase of the race
to develop a vaccine by the start of next year.

The Boston-based biotech said on Monday that it had begun the
first Phase III study of a vaccine in the US, a large-scale trial
that is usually the last before a new product is submitted for
regulatory approval.

The company’s shares were up as much as 10.6 percent before
paring some of their gains.

Read 10
remaining paragraphs

Source: FS – All – Science – News
Moderna begins first late-stage US trial of COVID-19
vaccine